128 related articles for article (PubMed ID: 25843412)
21. The effect of aspirin and various iontophoresis solution vehicles on skin microvascular reactivity.
Abou-Elenin K; Xydakis A; Hamdy O; Economides PA; Horton ES; Veves A
Microvasc Res; 2002 Jan; 63(1):91-5. PubMed ID: 11749076
[TBL] [Abstract][Full Text] [Related]
22. Acute, local effects of iontophoresed insulin and C-peptide on cutaneous microvascular function in Type 1 diabetes mellitus.
Delaney C; Shaw J; Day T
Diabet Med; 2004 May; 21(5):428-33. PubMed ID: 15089786
[TBL] [Abstract][Full Text] [Related]
23. Impairment of systemic microvascular endothelial and smooth muscle function in individuals with early-onset coronary artery disease: studies with laser speckle contrast imaging.
Souza EG; De Lorenzo A; Huguenin G; Oliveira GM; Tibiriçá E
Coron Artery Dis; 2014 Jan; 25(1):23-8. PubMed ID: 24172594
[TBL] [Abstract][Full Text] [Related]
24. Lack of a pharmacokinetic interaction between oral treprostinil and bosentan in healthy adult volunteers.
Gotzkowsky SK; Dingemanse J; Lai A; Mottola D; Laliberte K
J Clin Pharmacol; 2010 Jul; 50(7):829-34. PubMed ID: 20133511
[TBL] [Abstract][Full Text] [Related]
25. Microvascular endothelial function in subjects with Type 2 diabetes and the effect of lipid-lowering therapy.
Fegan PG; Shore AC; Mawson D; Tooke JE; MacLeod KM
Diabet Med; 2005 Dec; 22(12):1670-6. PubMed ID: 16401310
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of systemic microvascular endothelial function using laser speckle contrast imaging.
Cordovil I; Huguenin G; Rosa G; Bello A; Köhler O; de Moraes R; Tibiriçá E
Microvasc Res; 2012 May; 83(3):376-9. PubMed ID: 22326551
[TBL] [Abstract][Full Text] [Related]
27. An evaluation of the pharmacokinetics of treprostinil diolamine in subjects with hepatic impairment.
Peterson L; Marbury T; Marier J; Laliberte K
J Clin Pharm Ther; 2013 Dec; 38(6):518-23. PubMed ID: 24033615
[TBL] [Abstract][Full Text] [Related]
28. Metabolic syndrome individuals with and without type 2 diabetes mellitus present generalized vascular dysfunction: cross-sectional study.
Walther G; Obert P; Dutheil F; Chapier R; Lesourd B; Naughton G; Courteix D; Vinet A
Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):1022-9. PubMed ID: 25657309
[TBL] [Abstract][Full Text] [Related]
29. Transcutaneous application of the gaseous CO
Finžgar M; Frangež HB; Cankar K; Frangež I
Microvasc Res; 2021 Jan; 133():104100. PubMed ID: 33181169
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics of oral treprostinil sustained release tablets during chronic administration to patients with pulmonary arterial hypertension.
White RJ; Torres F; Allen R; Jerjes C; Pulido T; Yehle D; Howell M; Laliberte K; Marier JF; Tapson VF
J Cardiovasc Pharmacol; 2013 Jun; 61(6):474-81. PubMed ID: 23328389
[TBL] [Abstract][Full Text] [Related]
31. Assessment of endothelial and neurovascular function in human skin microcirculation.
Roustit M; Cracowski JL
Trends Pharmacol Sci; 2013 Jul; 34(7):373-84. PubMed ID: 23791036
[TBL] [Abstract][Full Text] [Related]
32. Treprostinil Iontophoresis in Idiopathic Pulmonary Arterial Hypertension.
Tonelli AR; Ahmed MK; Alkukhun L; Cikach F; Aulak K; Dweik RA
Am J Respir Crit Care Med; 2015 Oct; 192(8):1014-6. PubMed ID: 26469842
[No Abstract] [Full Text] [Related]
33. One-year experience with intravenous treprostinil for pulmonary arterial hypertension.
Benza RL; Tapson VF; Gomberg-Maitland M; Poms A; Barst RJ; McLaughlin VV
J Heart Lung Transplant; 2013 Sep; 32(9):889-96. PubMed ID: 23953817
[TBL] [Abstract][Full Text] [Related]
34. The effect of different meal compositions on the oral bioavailability of treprostinil diolamine in healthy volunteers.
Lim A; Wang-Smith L; Kates J; Laurent A; Kumar P; Laliberte K
J Clin Pharm Ther; 2013 Dec; 38(6):450-5. PubMed ID: 23927483
[TBL] [Abstract][Full Text] [Related]
35. Effect of skin temperature on skin endothelial function assessment.
Abraham P; Bourgeau M; Camo M; Humeau-Heurtier A; Durand S; Rousseau P; Mahe G
Microvasc Res; 2013 Jul; 88():56-60. PubMed ID: 23628293
[TBL] [Abstract][Full Text] [Related]
36. Sodium nitroprusside iontophoresis on the finger pad does not consistently increase skin blood flow in healthy controls and patients with systemic sclerosis.
Roustit M; Blaise S; Cracowski JL
Microvasc Res; 2009 May; 77(3):260-4. PubMed ID: 19272396
[TBL] [Abstract][Full Text] [Related]
37. Pilot study of the effects of local pressure on microvascular function in the diabetic foot.
Newton DJ; Bennett SP; Fraser J; Khan F; Belch JJ; Griffiths G; Leese GP
Diabet Med; 2005 Nov; 22(11):1487-91. PubMed ID: 16241911
[TBL] [Abstract][Full Text] [Related]
38. Transition from intravenous epoprostenol to intravenous treprostinil in pulmonary hypertension.
Gomberg-Maitland M; Tapson VF; Benza RL; McLaughlin VV; Krichman A; Widlitz AC; Barst RJ
Am J Respir Crit Care Med; 2005 Dec; 172(12):1586-9. PubMed ID: 16151039
[TBL] [Abstract][Full Text] [Related]
39. Digital iontophoresis of vasoactive substances as measured by laser Doppler imaging--a non-invasive technique by which to measure microvascular dysfunction in Raynaud's phenomenon.
Anderson ME; Moore TL; Lunt M; Herrick AL
Rheumatology (Oxford); 2004 Aug; 43(8):986-91. PubMed ID: 15199217
[TBL] [Abstract][Full Text] [Related]
40. Iontophoresis of endothelin receptor antagonists in rats and men.
Roustit M; Blaise S; Arnaud C; Hellmann M; Millet C; Godin-Ribuot D; Dufournet B; Boutonnat J; Ribuot C; Cracowski JL
PLoS One; 2012; 7(7):e40792. PubMed ID: 22808263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
